Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis (OA 2 Study)
This study is ongoing, but not recruiting participants.
Study NCT00704847   Information provided by Nordic Bioscience A/S
First Received: June 24, 2008   Last Updated: April 22, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Osteoarthritis
Additional conditions recognized in this trial
Osteoarthritis, Knee
More general conditions related to this trial
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Interventions listed in this trial
Oral Salmon Calcitonin
Oral Salmon Calcitonin (Placebo)
Additional drug interventions recognized in this trial
Calcitonin
Calcitonin Gene-Related Peptide
Salmon calcitonin
More general drug interventions related to this trial
Bone Density Conservation Agents
Cardiovascular Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Nordic Bioscience A/S
Novartis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services